{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:21:03Z","timestamp":1784996463435,"version":"3.55.0"},"reference-count":46,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Hemodialysis International"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>The effects of denosumab on bone mineral density (BMD) and metabolism in patients with end\u2010stage renal disease (ESRD) remain controversial. Hence, we performed a systematic review and meta\u2010analysis of observational studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The MEDLINE, EMBASE, and Cochrane Library databases were searched in June 2022 to identify studies that evaluated the risk of denosumab\u2010associated hypocalcemia and changes in bone metabolism, changes in BMD from baseline to post\u2010treatment in patients with ESRD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Findings<\/jats:title><jats:p>Twelve studies with 348 participants were included. The pooled incidence of hypocalcemia during denosumab treatment was 35.0% (95% confidence interval [CI], 25%\u201346%; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200963.6%). There were no significant changes in either the serum calcium or phosphate levels from the baseline to post\u2010treatment period; the mean differences were 0.04\u2009mg\/dL (95% CI, \u22120.12 to 0.20\u2009mg\/dL) and \u22120.39\u2009mg\/dL (95% CI, \u22120.89 to 0.12\u2009mg\/dL). We found significant changes in the alkaline phosphatase and parathyroid hormone levels; the standardized mean differences were \u22122.98 (95% CI, \u22125.36 to \u20130.59) and \u22123.12 (95% CI: \u20134.94 to \u20131.29), respectively. Denosumab may increase BMD, with mean differences of 9.10% (95% CI: 4.07%\u201314.13%) and 9.00% (95% CI: 5.93%\u201312.07%) for the femoral neck and lumbar spine, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Denosumab increased the BMDs of the lumbar spine and femoral neck in patients with ESRD. The onset of hypocalcemia must be carefully monitored during denosumab administration.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hdi.13098","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T11:54:35Z","timestamp":1685706875000},"page":"352-363","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of denosumab on bone mineral density and bone metabolism in patients with end\u2010stage renal disease: A systematic review and meta\u2010analysis"],"prefix":"10.1111","volume":"27","author":[{"given":"Zhaoyan","family":"Gu","sequence":"first","affiliation":[{"name":"Department of Endocrinology The Second Medical Center &amp; National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital  Beijing People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhui","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Oncology The Fifth Medical Center, Chinese PLA General Hospital and Chinese PLA Medical School  Beijing People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Chaoyang 1st Sanitarium for Retired Cadres of Beijing Garrison of the Chinese PLA  Beijing People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9675-3071","authenticated-orcid":false,"given":"Jianjun","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Nephrology The Chinese PLA Strategic Support Force Characteristic Medical Center  Beijing People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,6]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa192"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000414"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.12.024"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.01.024"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.2478\/jomb-2018-0042"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.264"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186846"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.12.024"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.4103\/sjmms.sjmms_639_21"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-012-0411-z"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00178.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3201"},{"key":"e_1_2_6_14_1","first-page":"458","article-title":"Bone metabolism, vascular calcifications and mortality: associations beyond mere coincidence","volume":"18","author":"Rodriguez Garcia M","year":"2005","journal-title":"J Nephrol"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01658"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S270829"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-020-00793-8"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2016.02.007"},{"key":"e_1_2_6_19_1","article-title":"Severe hypocalcemia and dramatic increase in parathyroid hormone after denosumab in a dialysis patient: a case report and review of the literature","volume":"2019","author":"Bhanot RD","year":"2019","journal-title":"Case Rep Nephrol"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1445-2197.2003.02748.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90054-Q"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1613"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1154"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1259"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-020-05391-3"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-016-0334-1"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.03.012"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59143-8"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6218129"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3676"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa359"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12029-3"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.5414\/CN110473"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4533-6"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2014.10.017"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2007.00319.x"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3705"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.9788"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809493"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1159\/000380960"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-021-00971-0"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002769"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.11.1847"}],"container-title":["Hemodialysis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hdi.13098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T07:27:26Z","timestamp":1696318046000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hdi.13098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1111\/hdi.13098"],"URL":"https:\/\/doi.org\/10.1111\/hdi.13098","archive":["Portico"],"relation":{},"ISSN":["1492-7535","1542-4758"],"issn-type":[{"value":"1492-7535","type":"print"},{"value":"1542-4758","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"2022-11-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}